| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.6B | $4.1B | $5.4B | $4.9B | $4.6B | $5.0B | $4.9B |
| Cost of Revenue | $8.5B | $8.6B | $7.7B | $11.4B | $10.7B | $9.8B | $10.6B | $9.9B |
| Gross Profit | $2.5B | $2.4B | $2.0B | $2.3B | $2.0B | $1.9B | $2.1B | $2.1B |
| R&D Expense | $0.8B | $0.8B | $0.5B | $0.5B | $0.5B | $0.4B | $0.5B | $0.4B |
| SG&A Expense | $5.1B | $5.1B | $4.2B | $4.2B | $4.2B | $4.0B | $4.5B | $4.3B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $1.0B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B |
| EPS (Basic) | $1.13 | $1.74 | $1.30 | $1.25 | $1.12 | $1.21 | $1.17 | $0.98 |
| EPS (Diluted) | $1.12 | $1.73 | $1.29 | $1.24 | $1.11 | $1.20 | $1.16 | $0.97 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $42.0B | $44.2B | $42.7B | $35.7B | $24.7B | $22.9B | $20.5B | $20.4B |
| Current Assets | $8.6B | $10.2B | $13.8B | $8.5B | $8.4B | $8.8B | $7.1B | $6.6B |
| Cash & Equivalents | — | — | — | $2.4B | $2.4B | $3.3B | $1.5B | $1.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.8B | $5.7B | $5.0B | $7.8B | $6.2B | $5.8B | $6.0B | $6.2B |
| Stockholders' Equity | $20.3B | $21.6B | $20.7B | $10.4B | $9.9B | $8.4B | $8.2B | $8.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $3.3B | $0.6B | $2.9B | $3.6B | $3.1B | $3.0B | $2.9B |
| Investing Cash Flow | $-0.6B | $-5.4B | $12.4B | $-5.3B | $-2.1B | $-0.7B | $-1.2B | $-2.7B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.5B | $0.6B | $0.5B | $0.6B | $0.6B |
| Financing Cash Flow | $-4.5B | $-2.5B | $-6.8B | $2.0B | $-2.4B | $-0.5B | $-1.4B | $-2.1B |